Literature DB >> 12197891

Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women.

Y Wang1, J Underwood, R Vaughan, A Harmer, C Doyle, T Lehner.   

Abstract

Studies in humans suggest that allo-immunization induces CC-chemokines, CD8-suppressor factors (SF) and anti-HIV immunity. Here we report that allo-immunization with unmatched leucocytes from partners of women with recurrent spontaneous abortion elicits specific antibodies to the CCR5 receptor. Such antibodies inhibit replication of M-tropic HIV-1 (R5) and MIP-1beta-mediated chemotaxis. These CCR5 antibodies were also found in the sera of multiparous women that were naturally immunized by semi-allogeneic fetal antigens. The specificity of these antibodies was demonstrated by adsorption with CCR5 transfected HEK-293 cells, a baculovirus CCR5 preparation and a peptide of the 2nd extra-cellular loop of CCR5. Allo-immunization also stimulated increased concentrations of the CXC chemokine, SDF-1alpha and CD8-SF that inhibit T-tropic HIV-1 (X4) replication. We suggest that allo- immunization may elicit (a) CC chemokines, CCR5 antibodies and CD8-SF that inhibit M-tropic HIV-1 infection and (b) the CXC chemokine SDF-1alpha and CD8-SF that inhibit T-tropic HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12197891      PMCID: PMC1906474          DOI: 10.1046/j.1365-2249.2002.01936.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

Review 1.  Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression.

Authors:  F Sallusto; A Lanzavecchia
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

2.  Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women.

Authors:  Y Wang; L Tao; E Mitchell; C Bravery; P Berlingieri; P Armstrong; R Vaughan; J Underwood; T Lehner
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

Review 3.  CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.

Authors:  C Mackewicz; J A Levy
Journal:  AIDS Res Hum Retroviruses       Date:  1992-06       Impact factor: 2.205

4.  CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.

Authors:  L Lopalco; C Barassi; C Pastori; R Longhi; S E Burastero; G Tambussi; F Mazzotta; A Lazzarin; M Clerici; A G Siccardi
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

5.  An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status.

Authors:  A L Landay; C E Mackewicz; J A Levy
Journal:  Clin Immunol Immunopathol       Date:  1993-10

Review 6.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

Authors:  T G Wegmann; H Lin; L Guilbert; T R Mosmann
Journal:  Immunol Today       Date:  1993-07

7.  Immunogenicity of the extracellular domains of C-C chemokine receptor 5 and the in vitro effects on simian immunodeficiency virus or HIV infectivity.

Authors:  T Lehner; C Doyle; Y Wang; K Babaahmady; T Whittall; L Tao; L Bergmeier; C Kelly
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

8.  Up-regulation of beta-chemokines and down-modulation of CCR5 co-receptors inhibit simian immunodeficiency virus transmission in non-human primates.

Authors:  T Lehner; Y Wang; M Cranage; L Tao; E Mitchell; C Bravery; C Doyle; K Pratt; G Hall; M Dennis; L Villinger; L Bergmeier
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

9.  Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge.

Authors:  B Zuber; J Hinkula; D Vödrös; P Lundholm; C Nilsson; A Mörner; M Levi; R Benthin; B Wahren
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

10.  HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.

Authors:  A J Vila-Coro; M Mellado; A Martín de Ana; P Lucas; G del Real; C Martínez-A; J M Rodríguez-Frade
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  10 in total

1.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

2.  Working group consultation: alloimmunity as a vaccine approach against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012.

Authors:  Anjali Singh; Jon Warren; Alan Schultz; Charles J Hackett; Opendra Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-23       Impact factor: 2.205

3.  Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.

Authors:  C Barassi; E Soprana; C Pastori; R Longhi; E Buratti; F Lillo; C Marenzi; A Lazzarin; A G Siccardi; L Lopalco
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers.

Authors:  W Jennes; D Evertse; M-Y Borget; B Vuylsteke; C Maurice; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

5.  Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies.

Authors:  Samir K Lakhashe; Madhuri R Thakar; K E Bharucha; Ramesh S Paranjape
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

6.  Brief Report: Enhanced Allogeneic Cellular Responses to Mismatched HLA-B Antigens Results in More Efficient Killing of HIV Infected Cells.

Authors:  Steffanie Sabbaj; Nicholas Scanlon; Victor Y Du; Yuge Wang; Jianming Tang; Eric Hunter; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-15       Impact factor: 3.731

7.  CCR5: From Natural Resistance to a New Anti-HIV Strategy.

Authors:  Lucia Lopalco
Journal:  Viruses       Date:  2010-02-05       Impact factor: 5.818

Review 8.  Development of a human leukocyte antigen-based HIV vaccine.

Authors:  Yufei Wang
Journal:  F1000Res       Date:  2018-06-22

9.  Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition - A Nested Case-Control Study in HIV-1 Serodiscordant Couples.

Authors:  Melinda S Suchard; Neil Martinson; Susan Malfeld; Debbie de Assis Rosa; Romel D Mackelprang; Jairam Lingappa; Xuanlin Hou; Helen Rees; Sinead Delany-Moretlwe; Hadassa Goldfein; Heena Ranchod; David Coetzee; Kennedy Otwombe; Lynn Morris; Caroline T Tiemessen; Dana M Savulescu
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

10.  Greater ethnic diversity correlates with lower HIV prevalence in Africa: justification for an alloimmunity vaccine.

Authors:  Christopher Zamani; Jared D Elzey; James Ek Hildreth
Journal:  HIV AIDS (Auckl)       Date:  2013-04-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.